FDA recall D-0370-2021
QMart · Class II · drug
Product
Burro en Primavera, 2 capsules, UPC 638632431055
Reason for recall
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.
Distribution
USA Nationwide
Key facts
- Status
- Ongoing
- Initiation date
- 2021-03-31
- Report date
- 2021-05-12
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Elmwood Park, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0370-2021